Nevertheless, investors are increasingly willing to endow biotech startups in the post- Human Genome Project era. Maybe that's why, out of almost 300 entries, both winners in a recent competition to devise the best business plan based on a new technology are biotech ventures. Or maybe it's not the formula that's so enticing. Maybe biotechs are just in vogue. On a relative basis I am not sure that healthcare has suddenly become better.
Industries come in and out of fashion.
Since top-tier universities are often the places to find idea people, but not so much the money people, it only made sense to find a way to get the two together. And it points venture capitalists and other investors in their direction. He said the company was born out of a dorm room at Duke University , in Durham, North Carolina, after he and his dormmates saw an untapped market of Michael Dells and Jerry Yangs. And the VCs apparently appreciate the help. Angie You will finish her PhD in cell biology at Harvard in June.